Concepedia

Publication | Open Access

PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.

Full Paper Access

144

Citations

13

References

2010

Year

Roberto Gedaly, Paul Angulo, Jonathan Hundley, Michael F. Daily, Changguo Chen, Alvaro Koch, B. Mark Evers
PubMed

Abstract

The combination of sorafenib and PI-103 can significantly inhibit EGF-stimulated Huh7 proliferation by blocking both Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.

References

YearCitations

Page 1